Literature DB >> 17219113

Indocyanine green angiographic findings of Dalen-Fuchs nodules in Vogt-Koyanagi-Harada disease.

Weiju Wu1, Feng Wen, Shizhou Huang, Guangwei Luo, Dezheng Wu.   

Abstract

PURPOSE: The purpose of this study was to analyze indocyanine green (ICG) angiographic findings of Dalen-Fuchs nodules in Vogt-Koyanagi-Harada (VKH) disease.
METHODS: ICG angiograms of 15 patients (30 eyes) with Dalen-Fuchs nodules in VKH disease of between 2 months and 5 years after the initial diagnosis were retrospectively studied. Findings of ICG angiography were compared with features of fundus fluorescein angiography (FFA).
RESULTS: Dalen-Fuchs nodules were easily found in the inferior (30 eyes, 100%) and temporal periphery (22 eyes, 73%) and showed two kinds of fluorescence in ICG angiography. In ten patients (20 eyes), the nodules showed small round hypofluorescent dark dots in the whole process of angiography, and the dark dots were larger in size than the nodules in FFA. Disease course in these patients was relatively long-between 1 year and 5 years. On clinical examination, the nodules were atrophic, and hyperpigmentation was found around them. In another five patients (ten eyes), parts of the nodules showed small hyperfluorescent dots in the early phase, but they were faint in the intermediate phase and became large, hypofluorescent dark dots in the late phase. Disease course in these patients was between 2 and 8 months. The nodules were bright yellow, fresh, and much larger than those in the first kind of ICG fluorescence.
CONCLUSIONS: Dalen-Fuchs nodules in VKH are mostly present in the inferior and temporal periphery. The two kinds of fluorescence of Dalen-Fuchs in ICG angiography may reflect obliteration of choriocapillaris under the nodules and different quantities of lipofuscin in the nodules at different time points of the disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17219113     DOI: 10.1007/s00417-006-0511-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.535


  10 in total

Review 1.  Vogt-Koyanagi-Harada disease.

Authors:  Ranjan Rajendram; Monica Evans; Narsing A Rao
Journal:  Int Ophthalmol Clin       Date:  2005

2.  Morphological variation of Dalén-Fuchs nodules in sympathetic ophthalmia.

Authors:  M Reynard; R S Riffenburgh; D S Minckler
Journal:  Br J Ophthalmol       Date:  1985-03       Impact factor: 4.638

3.  Sympathetic ophthalmia. Histopathologic and fluorescein angiographic correlation.

Authors:  D C Sharp; R A Bell; E Patterson; R M Pinkerton
Journal:  Arch Ophthalmol       Date:  1984-02

4.  Light and electron microscopic study of Dalén-Fuchs nodules in sympathetic ophthalmia.

Authors:  R L Font; B S Fine; E Messmer; J F Rowsey
Journal:  Ophthalmology       Date:  1983-01       Impact factor: 12.079

5.  Schematic interpretation of indocyanine green angiography in posterior uveitis using a standard angiographic protocol.

Authors:  C P Herbort; P LeHoang; Y Guex-Crosier
Journal:  Ophthalmology       Date:  1998-03       Impact factor: 12.079

6.  Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease.

Authors:  H Inomata; N A Rao
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

7.  Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature.

Authors:  R W Read; G N Holland; N A Rao; K F Tabbara; S Ohno; L Arellanes-Garcia; P Pivetti-Pezzi; H H Tessler; M Usui
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

8.  Pre-injection fluorescence in indocyanine green angiography.

Authors:  F C Piccolino; L Borgia; E Zinicola; M Iester; S Torrielli
Journal:  Ophthalmology       Date:  1996-11       Impact factor: 12.079

9.  Fluorescein angiographic appearance of Dalen-Fuchs nodules in sympathetic ophthalmia.

Authors:  R W Allinson; T D Le; T R Kramer; R W Snyder
Journal:  Ann Ophthalmol       Date:  1993-04

10.  Twenty cases of sympathetic ophthalmia.

Authors:  T Jennings; H H Tessler
Journal:  Br J Ophthalmol       Date:  1989-02       Impact factor: 4.638

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.